1-[4-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]phenyl]-N-[(2S)-1-[(2S,4R)-4-hydroxy-2-[[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]carbamoyl]pyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]piperidine-4-carboxamide
C45H52N8O5S — CID 169132727
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[4-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]phenyl]-N-[(2S)-1-[(2S,4R)-4-hydroxy-2-[[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]carbamoyl]pyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]piperidine-4-carboxamide
1-[4-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]phenyl]-N-[(2S)-1-[(2S,4R)-4-hydroxy-2-[[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]carbamoyl]pyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]piperidine-4-carboxamide (PubChem CID 169132727) has the molecular formula C45H52N8O5S and a molecular weight of 817.03 g/mol. Its IUPAC name is 1-[4-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]phenyl]-N-[(2S)-1-[(2S,4R)-4-hydroxy-2-[[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]carbamoyl]pyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]piperidine-4-carboxamide.
Molecular Properties
| Compound Name | 1-[4-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]phenyl]-N-[(2S)-1-[(2S,4R)-4-hydroxy-2-[[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]carbamoyl]pyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]piperidine-4-carboxamide |
|---|---|
| PubChem CID | 169132727 |
| Molecular Formula | C45H52N8O5S |
| Molecular Weight | 817.03 g/mol |
| Exact Mass | 816.38 |
| IUPAC Name | 1-[4-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]phenyl]-N-[(2S)-1-[(2S,4R)-4-hydroxy-2-[[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]carbamoyl]pyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]piperidine-4-carboxamide |
| SMILES | Cc1ncsc1-c1ccc([C@H](C)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)C2CCN(c3ccc(-c4cc(-c5ccccc5O)nnc4N)cc3)CC2)C(C)(C)C)cc1 |
| InChI | InChI=1S/C45H52N8O5S/c1-26(28-10-12-30(13-11-28)39-27(2)47-25-59-39)48-43(57)37-22-33(54)24-53(37)44(58)40(45(3,4)5)49-42(56)31-18-20-52(21-19-31)32-16-14-29(15-17-32)35-23-36(50-51-41(35)46)34-8-6-7-9-38(34)55/h6-17,23,25-26,31,33,37,40,54-55H,18-22,24H2,1-5H3,(H2,46,51)(H,48,57)(H,49,56)/t26-,33+,37-,40+/m0/s1 |
| InChIKey | XAIYAAJWUMVFAK-ALZQKILDSA-N |
| XLogP | 6.12 |
| TPSA | 186.90 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 11 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 59 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 817.03 |
| LogP ≤ 5 | 6.12 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 11 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 169132727 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.